Product Information
CLINDAMYCIN-BENZOYL PEROX 1-5% is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.7355 per GM under NDC 45802050901. Its NADAC has been published 283 times since Mar 24, 2021.
FDA first approved this application on Sep 21, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802050901
Classification
Generic
Dosage Form
KIT
Effective Date
8/19/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA202440FDA Approved
9/21/2015
TE Code
AB
On Market Since
2/3/2021
Price Statistics
The NADAC for CLINDAMYCIN-BENZOYL PEROX 1-5% has been published 283 times since Mar 24, 2021, and over the history we have for it it has declined 55.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7355 per GM |
|---|---|
| All-time high | $1.8527 (May 12, 2021) |
| All-time low | $0.6901 (Jun 17, 2026) |
| 52-week high | $0.8776 |
| 52-week low | $0.6901 |
| Median price | $0.8738 |
| Average price | $0.9860 |
| Largest weekly change | +35.1% (Jan 18, 2023) |
| Weeks tracked | 283 |
| Tracking since | Mar 24, 2021 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 37% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CLINDAMYCIN-BENZOYL PEROX 1-5%?
The current National Average Drug Acquisition Cost (NADAC) for CLINDAMYCIN-BENZOYL PEROX 1-5%, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.7355 per GM (NDC 45802050901), effective Aug 19, 2026.
How has the price of CLINDAMYCIN-BENZOYL PEROX 1-5% changed over time?
Over the history we have for it, the NADAC for CLINDAMYCIN-BENZOYL PEROX 1-5% has declined 55.9%. It has been tracked across 283 weekly CMS publications since Mar 24, 2021.
What are the highest and lowest recorded NADAC prices for CLINDAMYCIN-BENZOYL PEROX 1-5%?
Since Mar 24, 2021, the NADAC for CLINDAMYCIN-BENZOYL PEROX 1-5% has ranged from a low of $0.6901 (Jun 17, 2026) to a high of $1.8527 (May 12, 2021), with a median of $0.8738 per GM.
Are there cheaper alternatives to CLINDAMYCIN-BENZOYL PEROX 1-5%?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CLINDAMYCIN-BENZOYL PEROX 1-5%, is $0.4661 per GM — about 37% below CLINDAMYCIN-BENZOYL PEROX 1-5%.
Who manufactures CLINDAMYCIN-BENZOYL PEROX 1-5%?
CLINDAMYCIN-BENZOYL PEROX 1-5% (NDC 45802050901) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.